GFM Network News


Elanco Animal Health CEO Jeff Simmons speaks during an interview at the New York Stock Exchange (NYSE) on Sept. 20, 2018. (Photo: Reuters/Brendan McDermid)

Second activist investor buys into Elanco

Reuters — Hedge fund Starboard Value LP has taken a stake in Elanco Animal Health and nominated three directors to the animal healthcare company’s board, the Wall Street Journal reported Wednesday, citing people familiar with the matter. The WSJ report did not mention the size of Starboard’s stake in Elanco, which makes treatments for pets […] Read more

Elanco Animal Health CEO Jeff Simmons speaks during an interview at the New York Stock Exchange (NYSE) on Sept. 20, 2018. (Photo: Reuters/Brendan McDermid)

Elanco Animal Health wins U.S. approval to buy Bayer unit

Elanco to shed cattle pour-on brand, others for approval

Washington | Reuters — Elanco Animal Health has won U.S. antitrust approval to buy Bayer’s animal health business on condition that it sell assets to treat three ailments, two in dogs and one in cattle, the Federal Trade Commission said on Wednesday. The deal was valued at $7.6 billion when it was announced in August […] Read more


Chicks atop images from a genetic map of a chicken. (Peggy Greb photo courtesy ARS/USDA)

Elanco forgoes Canadian poultry insecticide rights for Bayer deal

Reuters — Elanco Animal Health has decided against acquiring Bayer’s Canadian distribution rights to several poultry insecticides, Canada’s Competition Bureau said on Tuesday, as it looks to complete a $7.6-billion deal. The U.S.-based company will also divest its canine ear infection treatment product Osurnia and Bayer’s feline dewormer Profender to address competition concerns about its […] Read more

Bayer’s cross symbol hangs in a terminal at Frankfurt International Airport. (Typhoonski/iStock Editorial/Getty Images)

Elanco gets EU’s conditional antitrust OK for Bayer deal

Approval calls for sale of Vecoxan brand, among others

Reuters/Staff — Elanco Animal Health secured antitrust clearance on Monday from the European Union to buy Bayer’s veterinary drugs unit, after pledging to sell some products to address competition concerns about the US$7.6 billion deal. The European Commission said the companies will sell either Elanco or Bayer’s products or those in the pipeline, including licenses, […] Read more





(PrevtecMicrobia.com)

Elanco buys swine PWD vaccine maker

Veterinary drugmaker Elanco Animal Health is expanding its space in the swine sector with a deal to buy the Quebec startup behind Coliprotec vaccines. Indianapolis-based Elanco announced Thursday it has paid $78.5 million to buy Prevtec Microbia, which is headquartered in Montreal with facilities in St-Hyacinthe. The Coliprotec line is meant to help protect pigs […] Read more